View Press Releases
-
BOC Sciences Shares Its Strategic Emphasis on NTPs during the Pandemic
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.
Aug 2, 2022
-
Vaxess Announces Launch of Phase 1 Trial For H1 Influenza Vaccine Patch
Company focused on creating shot-free future of vaccines; first human trial of Vaxess MIMIX™ vaccine patch will focus on administering influenza vaccine
Aug 2, 2022
-
Lyniate Merges with CareCom, Further Extending Capabilities of Interoperability Leader
-
Creative Biogene Launches Zebrafish Disease Models to Support Drug Discovery and Toxicology Research
-
IntegrateRNA Launches GalNAc-Oligonucleotide Conjugation Service to Support Oligonucleotides Therapeutic Research
-
MicroRNA Agomir Synthesis: Supporting New Drug Research with Cutting-Edge Chemical Synthesis Technology
-
Creative Bioarray Offers Clonality Analysis Service to Accelerate Biopharmaceutical or Biosimilar Development
-
Creative Bioarray Develops Full-service Support for Transgene Mapping
-
Creative Bioarray Has Developed Cell Immortalization Services to Support Potential Drug Development
-
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
GreenLight Biosciences and Samsung Biologics announce successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership
Jul 31, 2022
-
Creative Peptides Delivers Phage Display Services with Versatile Peptide Library
Creative Peptides delivers phage display services with a versatile phage peptide library, hoping to assist researchers in jumpstarting peptide drug screening.
Jul 31, 2022
-
BioIVT Announces Promotion of Dr. Richard Haigh to CEO
BioIVT, a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, announced the promotion of Richard Haigh, PhD, from Chief Operating Officer to Chief Executive Officer effective August 1.
Jul 31, 2022
-
Creative Biogene Released Complete C. elegans Cell Isolation and Culture Services
Creative Biogene released complete C. elegans cell isolation and culture services with high-quality data delivery, as well as in-depth scientific and technical support
Jul 31, 2022
-
Digital Health Summit 2022
-
Creative Biostructure Enables Protein Secondary Structure Investigation with Various Services
-
CD BioGlyco Offers Wide Solutions for Lipid Analysis
-
MCI Onehealth Partners with MDClone to Accelerate Research through Global Clinical Intelligence Offering
MCI Onehealth Partners with MDClone to Accelerate Research through Global Clinical Intelligence Offering By granting global partners access to real-world insights and synthetic data, the new partnership aims to accelerate research and inspire new therapy development to drive better patient outcomes
Jul 27, 2022
-
Artificial Intelligence poised to change healthcare industry
-
AI Takes Neuro MRI to the Next Level of Care
Artificial intelligence (AI) has become an essential feature of many subspecialties of radiology, particularly neuroradiology, which heavily relies on magnetic resonance imaging (MRI) to help diagnose conditions that afflict the central nervous system.
Jul 27, 2022
-
Samsung Biologics Reports Second Quarter 2022 Financial Results
Samsung Biologics announces second quarter 2022 financial results
Jul 27, 2022